NAMPT knockdown in mice remarkably reduced the tumor growth, whereas further examination of NAMPT by immunohistochemistry in 480 human breast cancer tissues, with tumor microarrays (TMA), showed that patients with elevated NAMPT expression, whether belonging to the TNBC group or not, had ominous prognosis. This evidence concerns the gene NAMPT and breast cancer.